{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T11:49:17Z","timestamp":1780400957492,"version":"3.54.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","valueinhealthjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.jval.2020.09.017","type":"journal-article","created":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T21:14:47Z","timestamp":1610572487000},"page":"274-280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Utility Decrements Associated With Diabetes and Related Complications: Estimates From a Population-Based Study in Germany"],"prefix":"10.1016","volume":"24","author":[{"given":"Michael","family":"Laxy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"K\u00e4hm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Holle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Thorand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Schwettmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian M.","family":"Karl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jval.2020.09.017_bib1","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s40273-015-0268-9","article-title":"The economic costs of type 2 diabetes: a global systematic review","volume":"33","author":"Seuring","year":"2015","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jval.2020.09.017_bib2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12889-018-6324-6","article-title":"The impact of diabetes on labour market participation: a systematic review of results and methods","volume":"19","author":"Pedron","year":"2019","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jval.2020.09.017_bib3","doi-asserted-by":"crossref","first-page":"120","DOI":"10.4239\/wjd.v8.i4.120","article-title":"Type 2 diabetes and quality of life","volume":"8","author":"Trikkalinou","year":"2017","journal-title":"World J Diabetes"},{"key":"10.1016\/j.jval.2020.09.017_bib4","doi-asserted-by":"crossref","first-page":"617","DOI":"10.2337\/diacare.28.3.617","article-title":"Associations of mortality and diabetes complications in patients with type 1 and type 2 diabetes: early treatment diabetic retinopathy study report no. 27","volume":"28","author":"Cusick","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jval.2020.09.017_bib5","first-page":"421","article-title":"Medical costs associated with type 2 diabetes complications and comorbidities","volume":"19","author":"Li","year":"2013","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.jval.2020.09.017_bib6","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-012527","article-title":"Cost burden of type 2 diabetes in Germany: results from the population-based KORA studies","volume":"6","author":"Ulrich","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.jval.2020.09.017_bib7","doi-asserted-by":"crossref","first-page":"971","DOI":"10.2337\/dc17-1763","article-title":"Health care costs associated with incident complications in patients with type 2 diabetes in Germany","volume":"41","author":"K\u00e4hm","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jval.2020.09.017_bib8","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/dme.12647","article-title":"The impact of diabetes-related complications on healthcare costs: new results from the UKPDS (UKPDS 84)","volume":"32","author":"Alva","year":"2015","journal-title":"Diabet Med"},{"key":"10.1016\/j.jval.2020.09.017_bib9","first-page":"176","article-title":"Direct medical costs of complications of diabetes in the United States: estimates for event-year and annual state costs (USD 2012)","volume":"17","author":"Ward","year":"2014","journal-title":"J\u00a0Med Econ"},{"key":"10.1016\/j.jval.2020.09.017_bib10","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1111\/dme.14213","article-title":"Assessment of excess medical costs for persons with type 2 diabetes according to age groups: an analysis of German health insurance claims data","volume":"37","author":"K\u00e4hm","year":"2020","journal-title":"Diabet Med"},{"key":"10.1016\/j.jval.2020.09.017_bib11","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jval.2015.10.010","article-title":"Changes in quality of life associated with complications of diabetes: results from the ADVANCE study","volume":"19","author":"Hayes","year":"2016","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2020.09.017_bib12","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jval.2014.03.003","article-title":"Review of utility values for economic modeling in type 2 diabetes","volume":"17","author":"Beaudet","year":"2014","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2020.09.017_bib13","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1177\/027298902400448902","article-title":"Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62)","volume":"22","author":"Clarke","year":"2002","journal-title":"Med Decis Making"},{"key":"10.1016\/j.jval.2020.09.017_bib14","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1111\/j.1524-4733.2009.00515.x","article-title":"QALYs: the basics","volume":"12","author":"Weinstein","year":"2009","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2020.09.017_bib16","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1477-7525-1-54","article-title":"The health utilities index (HUI): concepts, measurement properties and applications","volume":"1","author":"Horsman","year":"2003","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.jval.2020.09.017_bib17","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1007\/s11136-012-0322-4","article-title":"Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study","volume":"22","author":"Janssen","year":"2013","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jval.2020.09.017_bib18","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1464-5491.2010.03136.x","article-title":"The use of the EQ-5D preference-based health status measure in adults with type 2 diabetes mellitus","volume":"28","author":"Janssen","year":"2011","journal-title":"Diabet Med"},{"key":"10.1016\/j.jval.2020.09.017_bib19","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.jval.2016.05.018","article-title":"EQ-5D scores for diabetes-related comorbidities","volume":"19","author":"Sullivan","year":"2016","journal-title":"Value Health"},{"issue":"Suppl 1","key":"10.1016\/j.jval.2020.09.017_bib20","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1055\/s-2005-858235","article-title":"KORA: a research platform for population based health research","volume":"67","author":"Holle","year":"2005","journal-title":"Gesundheitswesen"},{"key":"10.1016\/j.jval.2020.09.017_bib21","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","article-title":"Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)","volume":"20","author":"Herdman","year":"2011","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jval.2020.09.017_bib22","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s40273-018-0623-8","article-title":"Is EQ-5D-5L better than EQ-5D-3L? A head-to-head comparison of descriptive systems and value sets from seven countries","volume":"36","author":"Janssen","year":"2018","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jval.2020.09.017_bib15","first-page":"1","article-title":"German value set for the EQ-5D-5L","author":"Ludwig","year":"2018","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jval.2020.09.017_bib23","series-title":"Validation of the CDC-RTI Diabetes Cost-Effectiveness Model","author":"Hoerger","year":"2009"},{"issue":"suppl 1","key":"10.1016\/j.jval.2020.09.017_bib24","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1185\/030079904X1980","article-title":"The CORE diabetes model: projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making","volume":"20","author":"Palmer","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jval.2020.09.017_bib25","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1007\/s00125-013-2940-y","article-title":"UKPDS outcomes model 2: a\u00a0new version of a model to simulate lifetime health outcomes of patients\u00a0with type 2 diabetes mellitus using data from the 30 year United\u00a0Kingdom Prospective Diabetes Study: UKPDS 82","volume":"56","author":"Hayes","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.jval.2020.09.017_bib26","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1477-7525-9-53","article-title":"Multimorbidity and health-related quality of life in the older population: results from the German KORA-age study","volume":"9","author":"Hunger","year":"2011","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.jval.2020.09.017_bib27","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s40273-020-00893-8","article-title":"A\u00a0comparison of the EQ-5D-3L and EQ-5D-5L","volume":"38","author":"Thompson","year":"2020","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jval.2020.09.017_bib28","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1477-7525-6-18","article-title":"EQ-5D visual analog scale and utility index values in individuals with diabetes and at risk for diabetes: findings from the Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes (SHIELD)","volume":"6","author":"Grandy","year":"2008","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.jval.2020.09.017_bib29","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1177\/0272989X06290495","article-title":"Preference-based EQ-5D index scores for chronic conditions in the United States","volume":"26","author":"Sullivan","year":"2006","journal-title":"Med Decis Making"},{"key":"10.1016\/j.jval.2020.09.017_bib30","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s40273-019-00822-4","article-title":"Performance of the UKPDS outcomes model 2 for predicting death and cardiovascular events in patients with type 2 diabetes mellitus from a German population-based cohort","volume":"37","author":"Laxy","year":"2019","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jval.2020.09.017_bib31","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/hec.2930","article-title":"The effect of diabetes complications on health-related quality of life: the importance of longitudinal data to address patient heterogeneity","volume":"23","author":"Alva","year":"2014","journal-title":"Health Econ"},{"key":"10.1016\/j.jval.2020.09.017_bib32","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s40273-019-00775-8","article-title":"Estimating quality of life decrements due to diabetes complications in the united states: the health utility index (HUI) Diabetes complication equation","volume":"37","author":"Shao","year":"2019","journal-title":"Pharmacoeconomics"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301520344594?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301520344594?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T01:22:25Z","timestamp":1761096145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301520344594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S1098301520344594"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2020.09.017","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utility Decrements Associated With Diabetes and Related Complications: Estimates From a Population-Based Study in Germany","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2020.09.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 ISPOR-The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}